Histone deacetylase inhibitors: SAHA (Vorinostat). A treatment option for advanced cutaneous T-cell lymphoma. Hematol Meeting Rep [Internet]. 2009 Jun. 23 [cited 2026 Aug. 3];2(5). Available from: https://journals.pagepress.net/hmr/article/view/724